 |
  |
Personalised Medicine |
|
11th
& 12th
November
2010 |
As a
concept, personalised medicine has the potential to
revolutionise healthcare and to massively improve
patient outcomes. Attend SMi’s 2010
Personalised Medicine conference to study the latest
developments in the science and the latest business
strategies and partnership models moving the
industry nearer to a personalised future.
 |
|
|
  |
DNVP Japan
Biotech Business Mission
15 Nov 2010 - 19 Nov 2010
The 2010 Japan Biotech Business
Mission aims to link up pharma
companies that are seeking out
potential R&D and business
collaborations with Japanese biotech
firms. Participants will gain a
better understanding of the Japanese
biotech scene through direct
meetings with innovative Japanese
companies and well-connected
contacts in the industry including
Japanese venture capitalists.
|
|
|
 |
|
COPD: Novel
Therapeutics and Management Strategies |
|
17th
& 18th
November 2010 |
This year, SMi offers its
2nd annual conference
COPD: Novel Therapeutics and Management
Strategies. In the Western world, COPD
is the only major cause of death that is on the
increase – despite this, COPD tends to be
neglected in terms of drug discovery and
development when compared to Asthma.
|
| |
|
|
|
|
|
Cell Based Assays |
|
22nd
& 23th
November 2010 |
Now that the majority of
screening assays employ the use of cell-based
technologies, robust cell-based assays are essential
for lead identification and the optimisation of
therapeutic candidates. Join SMi at their 3rd annual Cell-Based Assays
conference where they will assemble leading experts
from both industry and
academia to present you
with the latest
techniques, technologies and critical strategies
in a practical, case study focused environment.
|
| |
| |
| |
All rights reserved